Welcome to LookChem.com Sign In|Join Free
  • or
1-(3-iodophenyl)-N-methylmethanamine, also known as 3-Iodo-PMA, is a psychoactive designer drug that is structurally related to amphetamines and phenethylamines. It is recognized for its potent hallucinogenic properties and acts as a serotonin and dopamine releasing agent. This chemical compound is known to induce powerful psychedelic effects, which include hallucinations, altered perception, and changes in mood. However, it also carries a high risk of adverse effects such as agitation, paranoia, serotonin syndrome, and has been linked to fatal overdoses and long-term negative mental health impacts. Due to its potential for harm, it is classified as a controlled substance in many countries, making it illegal to manufacture, distribute, or possess.

90389-93-8

Post Buying Request

90389-93-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

90389-93-8 Usage

Uses

Used in Research and Development:
1-(3-iodophenyl)-N-methylmethanamine is used as a research chemical for the study of its psychoactive effects and potential interactions with the human brain's neurotransmitter systems. The application reason is to better understand the mechanisms of hallucinogenic substances and their impact on mental health, which could contribute to the development of new treatments for various psychiatric disorders.
Used in Forensic Analysis:
In the field of forensic science, 1-(3-iodophenyl)-N-methylmethanamine is used as a reference compound for the identification and analysis of designer drugs in criminal investigations. The application reason is to aid in the detection and prosecution of illegal drug manufacturing and distribution activities.
Used in Drug Policy and Regulation:
1-(3-iodophenyl)-N-methylmethanamine is also used in the development and enforcement of drug policy and regulation. The application reason is to establish legal frameworks and guidelines for the control and restriction of potentially harmful psychoactive substances, in order to protect public health and safety.

Check Digit Verification of cas no

The CAS Registry Mumber 90389-93-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,3,8 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 90389-93:
(7*9)+(6*0)+(5*3)+(4*8)+(3*9)+(2*9)+(1*3)=158
158 % 10 = 8
So 90389-93-8 is a valid CAS Registry Number.

90389-93-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (3-Iodo-benzyl)-methyl-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:90389-93-8 SDS

90389-93-8Relevant academic research and scientific papers

Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors

Cinelli, Maris A.,Li, Huiying,Chreifi, Georges,Poulos, Thomas L.,Silverman, Richard B.

supporting information, p. 3958 - 3978 (2017/05/19)

Neuronal nitric oxide synthase (nNOS) inhibition is a promising strategy to treat neurodegenerative disorders, but the development of nNOS inhibitors is often hindered by poor pharmacokinetics. We previously developed a class of membrane-permeable 2-amino

Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin

-

Page/Page column 15, (2008/06/13)

The present invention relates to a method of treating disorders by administering to a patient in need of such treatment a therapeutically effective amount of a compound of formula (I): wherein R1-R8 are as described herein, R4 being aryl or heteroaryl.

Benzylamines: Synthesis and evaluation of antimycobacterial properties

Meindl,Von Angerer,Schonenberger,Ruckdeschel

, p. 1111 - 1118 (2007/10/02)

The synthesis of benzylamines with various N-alkyl chains and substituents in the aromatic system as well as their evaluation on Mycobacterium tuberculosis H 37 Ra are described. The most active compounds in this test, N-methyl-3-chlorobenzylamine (MIC 10.2 μg/mL), N-methyl-3,5-dichlorobenzylamine (93, MIC 10.2 μg/mL), and N-butyl-3,5-difluorobenzylamine (MIC 6.4 μg/mL), also exhibited a marked inhibitory effect on Mycobacterium marinum and Mycobacterium lufu used for the determination of antileprotic properties. The combination of 93 with aminosalicylic acid, streptomycin, or dapsone exert marked supra-additive effects on M. tuberculosis H 37 Ra.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 90389-93-8